Oncotarget

Corrections:

Correction: Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer

PDF  |  How to cite

Oncotarget. 2019; 10:5385-5386. https://doi.org/10.18632/oncotarget.27186

Metrics: PDF 397 views  |   ?  

Mohamed A. Ahmed1,2, Edgar Selzer3, Wolfgang Dörr3,4, Gerd Jomrich5, Felix Harpain5, Gerd R. Silberhumer5, Leonhard Müllauer6, Klaus Holzmann1, Bettina Grasl-Kraupp1, Michael Grusch1, Walter Berger1, Brigitte Marian1

1 Institute of Cancer Research, Department of Medicine I, Medical University of Vienna, Austria
2 Radiation Biology Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Egypt
3 Department of Radiotherapy and Radiobiology, Medical University of Vienna, Austria
4 Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, Austria
5 Department of Surgery, Medical University Vienna, Austria
6 Clinical Institute of Pathology, Medical University Vienna, Austria

Published: September 03, 2019

This article has been corrected: While analyzing the same patient cohort for different markers, the authors realized a mistake in Table 2. The table reports on the correlation of radiation therapy response and FGFR4 immunoreactivity score. For both data sets, the stratification criteria were more stringent than mentioned in the table. However, the numerical results reported in the table were re-checked and found to be correct. The corrected Table 2 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2016; 7:60885–60895. DOI: https://doi.org/10.18632/oncotarget.12099.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27186